Skip Navigation


Rheumatology Advance Access originally published online on January 17, 2006
Rheumatology 2006 45(6):703-710; doi:10.1093/rheumatology/kei282
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
45/6/703    most recent
kei282v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jang, C.-H.
Right arrow Articles by Jue, D.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jang, C.-H.
Right arrow Articles by Jue, D.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Chloroquine inhibits production of TNF-{alpha}, IL-1ß and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes

C.-H. Jang, J.-H. Choi, M.-S. Byun and D.-M. Jue

Department of Biochemistry, College of Medicine, Catholic University of Korea, Seoul, South Korea.

Correspondence to: D.-M. Jue, Department of Biochemistry, College of Medicine, Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, South Korea. E-mail: dmjue{at}catholic.ac.kr

Objectives. TNF-{alpha}, IL-1 and IL-6 are known to have primary roles in the pathogenesis of rheumatoid arthritis and other inflammatory diseases. The anti-rheumatic drug chloroquine has been shown to inhibit TNF-{alpha}, IL-1 and IL-6 production from mononuclear phagocytes. We examined the underlying mechanisms involved in the chloroquine-induced inhibition of cytokine production.

Methods. Human peripheral blood mononuclear cells and monocytes/macrophages and monocytic U-937 and THP-1 cells were stimulated with lipopolysaccharide, and TNF-{alpha}, IL-1ß and IL-6 production was measured by ELISA. Levels of mRNA were measured by northern blotting and reverse transcription–polymerase chain reaction. Synthesis of 26-kDa TNF-{alpha} precursor was measured by metabolic labelling and immunoprecipitation analysis. Transcription rate was determined by nuclear run-on assay.

Results. TNF-{alpha} release from the cells was inhibited by chloroquine, whereas the steady-state level of TNF-{alpha} mRNA and synthesis of 26-kDa TNF-{alpha} precursor were not changed by chloroquine. In contrast, chloroquine-induced inhibition of IL-1ß and IL-6 release was accompanied by a decrease in their steady-state mRNA levels. The transcription rates of the IL-1ß and IL-6 genes were not changed by chloroquine, whereas the stability of IL-1ß and IL-6 mRNA was decreased by chloroquine. Weak-base amines such as methylamine and ammonium chloride had no effect on the production of TNF-{alpha}, whereas they partially blocked the production of IL-1ß and IL-6.

Conclusions. Our results indicate that chloroquine-mediated inhibition of TNF-{alpha}, IL-1ß and IL-6 synthesis occurs through different modes in lipopolysaccharide-stimulated human monocytes/macrophages: it blocks the conversion of cell-associated TNF-{alpha} precursor to mature soluble protein, whereas it reduces the levels of IL-1ß and IL-6 mRNA, at least in part, by decreasing their stability and by a pH-dependent mechanism.

KEY WORDS: Chloroquine, Rheumatoid arthritis, Cytokines, Gene regulation, Monocytes/macrophages, Inflammation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.